Literature DB >> 24527476

PURLs: treating migraine: the case for aspirin.

Vickie F Ingledue1, Anne Mounsey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24527476      PMCID: PMC3948481     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  6 in total

1.  Burden of migraine in the United States: disability and economic costs.

Authors:  X H Hu; L E Markson; R B Lipton; W F Stewart; M L Berger
Journal:  Arch Intern Med       Date:  1999-04-26

2.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

3.  Migraine prevalence by age and sex in the United States: a life-span study.

Authors:  T W Victor; X Hu; J C Campbell; D C Buse; R B Lipton
Journal:  Cephalalgia       Date:  2010-03-12       Impact factor: 6.292

Review 4.  The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.

Authors:  Todd A Smitherman; Rebecca Burch; Huma Sheikh; Elizabeth Loder
Journal:  Headache       Date:  2013-03-07       Impact factor: 5.887

Review 5.  Aspirin with or without an antiemetic for acute migraine headaches in adults.

Authors:  Varo Kirthi; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

6.  Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting.

Authors:  Trevor S Gibbs; Alan B Fleischer; Steven R Feldman; Maria C Sam; Cormac A O'Donovan
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

  6 in total
  1 in total

Review 1.  Targeting TRP channels for novel migraine therapeutics.

Authors:  Gregory Dussor; J Yan; Jennifer Y Xie; Michael H Ossipov; David W Dodick; Frank Porreca
Journal:  ACS Chem Neurosci       Date:  2014-08-29       Impact factor: 4.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.